Latest News

  • Charles River Partners with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies

    Diagnostics World News Brief | Charles River announced that it has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offers consistent and efficient reprogramming of human cells for use in research, drug discovery, and cell therapies.

    Dec 11, 2019
  • The Case For Lung Cancer Screening: Lessons from Lahey Health

    Diagnostics World News | Most patients, as well as most primary care physicians, consider lung cancer to be highly lethal. That’s because early-stage disease tends to be discovered by accident rather than intentionally through screening, leading Lahey Hospital & Medical Center to develop a high-volume CT lung cancer screening program, which is scanning about 65% of the eligible population with impressive results.

    Dec 9, 2019
  • Sight Diagnostics Receives FDA Clearance For Blood Test Device

    Diagnostics World News | Sight Diagnostics' AI-based blood diagnostics device—called OLO—recently received 510(k) clearance for the US Food and Drug Administration (FDA), allowing the device to be marketed and sold in the US.

    Dec 6, 2019
  • Veracyte Acquires nCounter Platform For Diagnostics

    Diagnostics World News | Veracyte announced today that it has executed a definitive agreement with NanoString for the exclusive global license to the nCounter platform for diagnostic use as well as other tests for $40 million in cash and $10 million in stock.

    Dec 3, 2019
  • Proscia, Vela, Certara, and More: News From November 2019

    Diagnostics World News | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Proscia, Vela, Certara, and more.

    Nov 27, 2019
  • Research Unraveling The Mysteries of the Human Placenta

    Diagnostics World News | Researchers recently took a step towards unraveling the "black box" of pregnancy with a new imaging technique called pseudo-continuous arterial spin labeling magnetic resonance imaging (pCASL MRI), which tracks maternal blood flow to the placenta.

    Nov 26, 2019
  • Follow The Money: Investments and Funding Rounds for November

    Diagnostics World News | Some of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.

    Nov 22, 2019